These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32002826)

  • 81. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
    Norman AB; Battaglia G; Creese I
    Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding.
    Jasper JR; Lesnick JD; Chang LK; Yamanishi SS; Chang TK; Hsu SA; Daunt DA; Bonhaus DW; Eglen RM
    Biochem Pharmacol; 1998 Apr; 55(7):1035-43. PubMed ID: 9605427
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Spiroxatrine augments fluoxetine-induced reduction of ethanol intake by the P line of rats.
    McBride WJ; Murphy JM; Lumeng L; Li TK
    Pharmacol Biochem Behav; 1989 Oct; 34(2):381-6. PubMed ID: 2533688
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Delineation of three pharmacological subtypes of alpha 2-adrenoceptor in the rat kidney.
    Uhlén S; Wikberg JE
    Br J Pharmacol; 1991 Nov; 104(3):657-64. PubMed ID: 1665747
    [TBL] [Abstract][Full Text] [Related]  

  • 85. 2-(2-Aminoethyl)-quinoline (D-1997): a novel agonist at 5-hydroxytryptamine1-like receptors in the canine basilar artery.
    Terrón JA; López-Muñoz FJ; Hong E; Villalón CM
    Arch Int Pharmacodyn Ther; 1994; 327(1):56-68. PubMed ID: 7944828
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Synthesis, in vitro and in vivo pharmacological evaluation of serotoninergic ligands containing an isonicotinic nucleus.
    Fiorino F; Ciano A; Magli E; Severino B; Corvino A; Perissutti E; Frecentese F; Di Vaio P; Izzo AA; Capasso R; Massarelli P; Nencini C; Rossi I; Kędzierska E; Orzelska-Gòrka J; Bielenica A; Santagada V; Caliendo G
    Eur J Med Chem; 2016 Mar; 110():133-50. PubMed ID: 26820556
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase.
    Bruins Slot LA; De Vries L; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2006 Mar; 534(1-3):63-70. PubMed ID: 16497294
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
    Piletz JE; Zhu H; Chikkala DN
    J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
    [TBL] [Abstract][Full Text] [Related]  

  • 89. 5-(Sulfonyl)oxy-tryptamines and ethylamino side chain restricted derivatives. Structure-affinity relationships for h5-HT1B and h5-HT1D receptors.
    Barf T; Wikström H; Pauwels PJ; Palmier C; Tardif S; Lundmark M; Sundell S
    Bioorg Med Chem; 1998 Sep; 6(9):1469-79. PubMed ID: 9801818
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
    Hussain MB; Marshall I
    Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
    Sallinen J; Höglund I; Engström M; Lehtimäki J; Virtanen R; Sirviö J; Wurster S; Savola JM; Haapalinna A
    Br J Pharmacol; 2007 Feb; 150(4):391-402. PubMed ID: 17220913
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Synthesis and molecular modeling of 1H-pyrrolopyrimidine-2,4-dione derivatives as ligands for the α1-adrenoceptors.
    Pittalà V; Siracusa MA; Modica MN; Salerno L; Pedretti A; Vistoli G; Cagnotto A; Mennini T; Romeo G
    Bioorg Med Chem; 2011 Sep; 19(17):5260-76. PubMed ID: 21802308
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
    J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Tethered yohimbine analogs as selective human alpha2C-adrenergic receptor ligands.
    Bavadekar SA; Ma G; Mustafa SM; Moore BM; Miller DD; Feller DR
    J Pharmacol Exp Ther; 2006 Nov; 319(2):739-48. PubMed ID: 16873606
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Revisiting the Pharmacodynamic Uroselectivity of
    Quaresma BMCS; Pimenta AR; Santos da Silva AC; Pupo AS; Romeiro LAS; Silva CLM; Noël F
    J Pharmacol Exp Ther; 2019 Oct; 371(1):106-112. PubMed ID: 31285236
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Structural Insight into the Mechanism of 4-Aminoquinolines Selectivity for the alpha2A-Adrenoceptor.
    Li Z; Li J; Liu L; Deng W; Liu Q; Liu R; Zhang W; He Z; Fan L; Yang Y; Duan Y; Hou H; Wang X; Yang Z; Wang X; Chen S; Wang Y; Huang N; Chen J
    Drug Des Devel Ther; 2020; 14():2585-2594. PubMed ID: 32694911
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
    Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
    J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Application of quantitative structure-activity relationship models of 5-HT1A receptor binding to virtual screening identifies novel and potent 5-HT1A ligands.
    Luo M; Wang XS; Roth BL; Golbraikh A; Tropsha A
    J Chem Inf Model; 2014 Feb; 54(2):634-47. PubMed ID: 24410373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.